SPAIN: EU researchers use nanoparticles to help drugs target tumours
January 1st, 2009
By Keith Nuthall
A group of European universities are banding together to create potentially valuable nanotechnology that could help pharmaceutical companies better target their anti-cancer drugs against tumours. The aim is to reduce the need to use wide-ranging chemotherapy and radiotherapy, which can cause patients to suffer from so many side-effects they sometimes wished their tumours had been left alone.
And so it has long been the aim of pharmaceutical companies and cancer researchers to devise means of targeting therapies, so that it is the tumour that ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.